Clinical trial
A Prospective, Randomized, and Controlled Study Comparing Two Treatment Strategies (Dose REduction of Antipsychotics vs. Maintenance Treatment) in Patients With Schizophrenia Spectrum Disorder After Stratification Based on Patients' Psychotic PHENotype: a Personalized Medicine Approach
NCT07152184 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, and Controlled Study Comparing Two Treatment Strategies (Dose REduction of Antipsychotics vs. Maintenance Treatment) in Patients With Schizophrenia Spectrum Disorder After Stratification Based on Patients' Psychotic PHENotype: a Personalized Medicine Approach
- Lead sponsor
- University Hospital, Strasbourg, France
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- February 1, 2032
- Enrollment
- 288 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nlm classification wm 203, psychology:schizophrenic psychology, patient with schizophrenia spectrum disorder, schizophrenia spectrum and other psychotic disorders